Vitality Watch

Dossier clinicaltrials trial early 09-nov-2026
Small or early-phase human trial or pilot study

Effect of Collagen and MSM Supplementation on Advanced Glycation End Products in Skin: Part B of the TO-COSKIN4 Study

Key claim: A placebo-controlled trial substudy in women aged 40 to 65 is evaluating whether 16 weeks of daily oral collagen, MSM, and vitamin C supplementation reduces skin advanced glycation end products.

Abstract

This nested substudy (Part B) of the VIST TO-COSKIN4 study (NCT07345195) evaluates whether 16 weeks of daily dietary supplementation with two investigational products containing collagen, methylsulfonylmethane (MSM) and vitamin C affects advanced glycation end products (AGEs) in the skin, compared with placebo. AGEs are compounds formed when sugars bind to proteins such as collagen, and they accumulate in the skin with age. They are assessed non-invasively by skin autofluorescence on the forearm. Part B includes the same participants (healthy women aged 40 to 65 years), randomisation and visits as the main study. The primary objective is to evaluate the effect of each investigational product, compared with placebo, on skin autofluorescence after 16 weeks; the secondary objective is to evaluate the effect after 8 weeks.

Why this matters

A placebo-controlled trial substudy in women aged 40 to 65 is evaluating whether 16 weeks of daily oral collagen, MSM, and vitamin C supplementation reduces skin advanced glycation end products.

Source

Link

Briefing card

Effect of Collagen and MSM Supplementation on Advanced Glycation End Products in Skin: Part B of the TO-COSKIN4 Study
Stage: trial early · clinicaltrials · 09-nov-2026

A placebo-controlled trial substudy in women aged 40 to 65 is evaluating whether 16 weeks of daily oral collagen, MSM, and vitamin C supplementation reduces skin advanced glycation end products.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT07925437

build build 880 · 2bcef25 · 2026-11-18